⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DBVT News
DBV Technologies S.A.
DBV Technologies révise sa participation à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs
globenewswire.com
DBVT
Form 8-K
sec.gov
DBVTF
DBVT
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
globenewswire.com
DBVT
Combined General Meeting of June 3, 2026
globenewswire.com
DBVT
DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq
globenewswire.com
DBVT
Form 8-K
sec.gov
DBVT
DBVTF
Form 8-K
sec.gov
DBVTF
DBVT
DBV Technologies publie ses résultats financiers du 1er trimestre 2026
globenewswire.com
DBVT
Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight
globenewswire.com
AMGN
AZN
DBVT
GSK
Form 8-K
sec.gov
DBVTF
DBVT